Holy GRAIL6 Jun 2024 11:15
Eyes on GRAIL and how much they are valued as they plan IPO spin-off from illumina next week.
Once considered the Holy Grail bought for $8billion, now words on the street saying it is likely to float for around $500m -1bn.. a fraction of what is was worth.
Reasons? Similar to Angle, burning cash and commercialisation not taking off.
Not just Angle Plc, it seems to be a broad issue of commercialisation issues across all things diagnostic blood test related. Time will tell... I still think there is huge potential, the question is when?
imo,dyor.